Products from TargetMol

TargetMol

TargetMol, based in Boston, Massachusetts, was founded in 2015 and is a drug screening expert in the life science community. The company offers diverse compound libraries, including FDA-approved libraries, and covers a broad spectrum of small molecule compounds such as inhibitors and agonists as well as recombinant proteins and natural products. TargetMol's products are used by researchers worldwide in areas such as cancer research, neurobiology, inflammation, immunology and metabolism.

More information at: www.targetmol.com

Go to the catalogs of TargetMol

12256 from 12257 pages
No results were found for the filter!
K203
K203

Item number: TGM-T62857-100mg

Description: K203 is a potent tabun-inhibited AChE reactivator and is an important antidote to organophosphorus poisoning. Target: Others
MW: 458.15 D
From 1,440.00€ *
Review
CK2-IN-3
CK2-IN-3

Item number: TGM-T62862-100mg

Description: CK2-IN-3 is a potent and selective CK2 inhibitor (Kd: 12 nM) with IC50 values of 1.51 µM for CK2alpha and 7.64 µM for CK2alpha'. CK2-IN-3 can be used in cancer research. Target: Others
MW: 458.46 D
From 1,440.00€ *
Review
844-TFM
844-TFM

Item number: TGM-T62866-100mg

Description: 844-TFM is an NBTI (novel bacterial topoisomerase inhibitor) DNA gyrase inhibitor (IC50: 1.5 µM). 844-TFM exhibits bactericidal activity against Mycobacterium abscessus. Target: Others
MW: 458.48 D
From 1,440.00€ *
Review
FABPs ligand 6
FABPs ligand 6

Item number: TGM-T62870-25mg

Description: FABPs ligand 6 (MF6) is an inhibitor of FABP5 (Kd: 874 nM) and FABP7 (Kd: 20 nM), and can be used in the study of multiple sclerosis. Target: Others
MW: 458.52 D
1,032.00€ *
Review
LRRK2-IN-6
LRRK2-IN-6

Item number: TGM-T62871-100mg

Description: LRRK2-IN-6 (compound 22) is an orally active, selective leucine-rich repeat protein kinase 2 (LRRK2) inhibitor with blood-brain barrier permeability, inhibiting GS LRRK2 (IC50: 4.6 µM) and WT LRRK2 (IC50: 49 µM). LRRK2-IN-6 exhibited inhibitory effects on the autophosphorylation of LRRK2 at Ser1292 and...
MW: 458.52 D
From 1,440.00€ *
Review
Anticancer agent 14
Anticancer agent 14

Item number: TGM-T62873-100mg

Description: Anticancer agent 14 is a lead compound (IC50: 0.20-0.65 µM) that blocks the cell cycle of breast cancer cells, induces apoptosis, and causes loss of mitochondrial membrane potential. Target: Others
MW: 458.59 D
From 1,440.00€ *
Review
Zalunfiban dihydrochloride
Zalunfiban dihydrochloride

Item number: TGM-T62878-100mg

Description: Zalunfiban (RUC-4) dihydrochloride is a selective and potent platelet alphaIIbbeta3 antagonist with an IC50 of 45 nM, suitable for studying myocardial infarction. Target: Others
MW: 459.35 D
From 1,023.00€ *
Review
alpha-Glucosidase-IN-19
alpha-Glucosidase-IN-19

Item number: TGM-T62891-100mg

Description: Alpha-Glucosidase-IN-19 (Compound 6B) is an orally active alpha-glucosidase inhibitor (IC50: 3.63 µM) with antidiabetic effects. Target: Others
MW: 459.6 D
From 1,440.00€ *
Review
AZ-PFKFB3-67 quarterhydrate
AZ-PFKFB3-67 quarterhydrate

Item number: TGM-T62894-100mg

Description: AZ-PFKFB3-67 quarterhydrate is a selective and potent inhibitor of the metabolic kinase PFKFB3 kinase, acting on PFKFB3 (IC50: 11 nM), PFKFB2 (IC50: 159 nM) and PFKFB1 (IC50: 1130 nM). Target: Others
MW: 460.01 D
From 1,127.00€ *
Review
EZH2-IN-12
EZH2-IN-12

Item number: TGM-T62896-100mg

Description: EZH2-IN-12 (Compound 5) is a potent inhibitor of EZH2, which has potential for studies of CNS malignancies. Target: Others
MW: 460.35 D
From 1,440.00€ *
Review
GLS-1-IN-1
GLS-1-IN-1

Item number: TGM-T62905-100mg

Description: GLS-1-IN-1 (compound 1d) is a GLS-1 inhibitor effective against Hep G2, MCF 7, and MCF 10A cells. Target: Others
MW: 460.57 D
From 1,440.00€ *
Review
TAS-117 hydrochloride
TAS-117 hydrochloride

Item number: TGM-T62907-25mg

Description: TAS-117 hydrochloride is a selective, potent, orally active allosteric Akt inhibitor, acting on Akt1 (IC50: 4.8 nM), Akt2 (IC50: 1.6 nM) and Akt3 (IC50: 44 nM). TAS-117 hydrochloride stimulates anti-myeloma activity, enhances lethal endoplasmic reticulum stress induced by proteasome inhibition, and can...
MW: 460.96 D
From 1,763.00€ *
Review
12256 from 12257 pages